ZA200802247B - Chimeric antibodies with new world primate regions - Google Patents

Chimeric antibodies with new world primate regions

Info

Publication number
ZA200802247B
ZA200802247B ZA200802247A ZA200802247A ZA200802247B ZA 200802247 B ZA200802247 B ZA 200802247B ZA 200802247 A ZA200802247 A ZA 200802247A ZA 200802247 A ZA200802247 A ZA 200802247A ZA 200802247 B ZA200802247 B ZA 200802247B
Authority
ZA
South Africa
Prior art keywords
regions
chimeric antibodies
new world
world primate
primate
Prior art date
Application number
ZA200802247A
Other languages
English (en)
Inventor
Jennings Philip Anthony
Doyle Anthony Gerard
Clarke Adam William
Original Assignee
Arana Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2005904406A external-priority patent/AU2005904406A0/en
Application filed by Arana Therapeutics Ltd filed Critical Arana Therapeutics Ltd
Publication of ZA200802247B publication Critical patent/ZA200802247B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA200802247A 2005-08-15 2006-08-15 Chimeric antibodies with new world primate regions ZA200802247B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2005904406A AU2005904406A0 (en) 2005-08-15 New World Antibodies

Publications (1)

Publication Number Publication Date
ZA200802247B true ZA200802247B (en) 2009-08-26

Family

ID=37757238

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA200802246A ZA200802246B (en) 2005-08-15 2006-08-15 Engineered antibodies with new world primate framework regions
ZA200802247A ZA200802247B (en) 2005-08-15 2006-08-15 Chimeric antibodies with new world primate regions

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ZA200802246A ZA200802246B (en) 2005-08-15 2006-08-15 Engineered antibodies with new world primate framework regions

Country Status (13)

Country Link
EP (1) EP1945669A4 (de)
JP (1) JP2009504686A (de)
KR (1) KR20080068005A (de)
CN (2) CN101287763A (de)
AU (1) AU2006281981A1 (de)
BR (2) BRPI0614430A2 (de)
CA (1) CA2619245A1 (de)
MX (1) MX2008002161A (de)
NO (1) NO20080800L (de)
NZ (1) NZ565904A (de)
RU (1) RU2008110058A (de)
WO (1) WO2007019621A1 (de)
ZA (2) ZA200802246B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS20070027A (en) 2004-07-26 2008-11-28 Biogen Idec Ma Inc., Anti-cd154 antibodies
KR20090039666A (ko) 2006-02-01 2009-04-22 아라나 테라퓨틱스 리미티드 도메인 항체 구조체
JP5721951B2 (ja) * 2007-03-22 2015-05-20 バイオジェン アイデック マサチューセッツ インコーポレイテッド 抗体、抗体誘導体、および抗体断片を含む、ｃｄ１５４に特異的に結合する結合タンパク質ならびにその使用
CA2733742A1 (en) * 2008-08-14 2010-02-18 Cephalon Australia Pty Ltd Variant domain antibodies
RU2535034C2 (ru) * 2010-08-06 2014-12-10 Олег Ильич Эпштейн Лекарственное средство и способ профилактики инфицирования вич, профилактики и лечения заболеваний, вызываемых вич или ассоциированных с вич, в том числе спида
RU2517085C2 (ru) * 2010-08-06 2014-05-27 Олег Ильич Эпштейн Комплексное лекарственное средство и способ профилактики инфицирования вич, профилактики и лечения заболеваний, вызываемых вич или ассоциированных с вич, в том числе спида
RU2516931C2 (ru) * 2010-08-06 2014-05-20 Олег Ильич Эпштейн Способ и композиция для профилактики инфицирования вич, профилактики и лечения заболеваний, вызываемых вич или ассоциированных с вич, в том числе спида
RU2577299C2 (ru) * 2011-07-04 2016-03-10 Олег Ильич Эпштейн Способ лечения инфекционных заболеваний и комплексное лекарственное средство для лечения инфекционных заболеваний
RU2519862C2 (ru) * 2010-08-06 2014-06-20 Олег Ильич Эпштейн Комплексное лекарственное средство и способ профилактики и лечения инфекционных вирусных заболеваний
RU2535033C2 (ru) * 2010-08-06 2014-12-10 Олег Ильич Эпштейн Лекарственное средство и способ профилактики инфицирования вич, профилактики и лечения заболеваний, вызываемых вич или ассоциированных с вич, в том числе спида
RU2521392C2 (ru) * 2010-08-06 2014-06-27 Олег Ильич Эпштейн Комплексное лекарственное средство для лечения вирусных заболеваний и способ лечения вирусных заболеваний
RU2505312C2 (ru) * 2010-08-06 2014-01-27 Олег Ильич Эпштейн Комплексное лекарственное средство для лечения гриппа различных типов
RU2502521C2 (ru) * 2010-08-06 2013-12-27 Олег Ильич Эпштейн Комплексное лекарственное средство для лечения бактериальных инфекций и способ лечения бактериальных инфекций
RU2579262C1 (ru) * 2014-10-02 2016-04-10 Мапикс Эс.Эй.Ар.Эл. Лекарственное средство для лечения инфекционных заболеваний
CL2015002152A1 (es) * 2015-07-31 2016-06-03 Pontificia Universidad Católica De Chile Anticuerpos monoclonales específicos para el antígeno p del virus respiratorio sincicial humano (vrsh), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnostico de la infección causada por vrsh

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0605442B1 (de) * 1991-07-25 2003-04-16 Idec Pharmaceuticals Corporation Rekombinante antikörper zur humanen therapie
US6569431B2 (en) * 2000-10-17 2003-05-27 The Regents Of The University Of California Recombinant antibody fragments as autoantibody antagonists
US7235643B2 (en) * 2000-11-07 2007-06-26 Morphotek, Inc. Antibodies and methods for generating genetically altered antibodies with high affinity
EP2366718A3 (de) * 2002-06-28 2012-05-02 Domantis Limited Ligand
AU2004290016A1 (en) * 2003-11-07 2005-05-26 Amgen Inc. Monkey immunoglobulin sequences

Also Published As

Publication number Publication date
CA2619245A1 (en) 2007-02-22
ZA200802246B (en) 2009-09-30
NZ565904A (en) 2012-02-24
CN101287763A (zh) 2008-10-15
BRPI0614430A2 (pt) 2011-03-29
JP2009504686A (ja) 2009-02-05
WO2007019621A1 (en) 2007-02-22
EP1945669A4 (de) 2009-07-22
CN101287762A (zh) 2008-10-15
MX2008002161A (es) 2008-04-22
RU2008110058A (ru) 2009-09-27
AU2006281981A1 (en) 2007-02-22
BRPI0614867A2 (pt) 2012-01-31
KR20080068005A (ko) 2008-07-22
NO20080800L (no) 2008-05-09
EP1945669A1 (de) 2008-07-23

Similar Documents

Publication Publication Date Title
ZA200802247B (en) Chimeric antibodies with new world primate regions
EP1945668A4 (de) Synthetische antikörper mit framework-regionen von neuweltprimaten
EP1969009A4 (de) Chimäre antikörper mit anteilen von bindungsregionen neuer-welt-primaten
HK1218126A1 (zh) 抗體
PT1874927E (pt) Celulases melhoradas
IL187106A (en) Sclerostin binds antibody
IL190472A0 (en) Anti-glypican-3 antibody
AP2007004243A0 (en) Antibodies to myostatin
EP1854410A4 (de) Biosensor mit angekoppelter nadel
GB0503546D0 (en) Antibody
GB0517487D0 (en) Antibodies
EP1896047A4 (de) Antikörper gegen gfr-alpha-3
GB0505489D0 (en) Antibodies
GB0512278D0 (en) Antibodies
GB0505054D0 (en) Antibodies
GB0519883D0 (en) Antibodies
GB0509392D0 (en) Improvements to the controllable petrol can
GB0616587D0 (en) Intelligent buggy
GB0521710D0 (en) Fork extension
GB0606276D0 (en) Antibodies
GB0607376D0 (en) Antibodies
GB0503580D0 (en) Travel phone
GB0500400D0 (en) Antibody
GB0501709D0 (en) H/h/t
GB0501876D0 (en) Hand-utility interface